Minami Yasunori, Minami Tomohiro, Ueshima Kazuomi, Yagyu Yukinobu, Tsurusaki Masakatsu, Okada Takuya, Hori Masatoshi, Kudo Masatoshi, Murakami Takamichi
Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi Osaka-Sayama, Osaka 589-8511, Japan.
Department of Radiology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi Osaka-Sayama, Osaka 589-8511, Japan.
Cancers (Basel). 2021 Mar 23;13(6):1460. doi: 10.3390/cancers13061460.
We investigate the feasibility of image fusion application for ablative margin assessment in radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) and possible causes for a wrong initial evaluation of technical success through a side-by-side comparison.
A total of 467 patients with 1100 HCCs who underwent RFA were reviewed retrospectively. Seventeen patients developed local tumor progressions (LTPs) (median size, 1.0 cm) despite initial judgments of successful ablation referring to contrast-enhanced images obtained in the 24 h after ablation. The ablative margins were reevaluated radiologically by overlaying fused images pre- and post-ablation.
The initial categorizations of the 17 LTPs had been grade A (absolutely curative) ( = 5) and grade B (relatively curative) ( = 12); however, the reevaluation altered the response categories to eight grade C (margin-zero ablation) and nine grade D (existence of residual HCC). LTP occurred in eight patients re-graded as C within 4 to 30.3 months (median, 14.3) and in nine patients re-graded as D within 2.4 to 6.7 months (median, 4.2) ( = 0.006). Periablational hyperemia enhancements concealed all nine HCCs reevaluated as grade D.
Side-by-side comparisons carry a risk of misleading diagnoses for LTP of HCC. Overlay fused imaging technology can be used to evaluate HCC ablative margin with high accuracy.
我们通过并排比较,研究图像融合技术在肝细胞癌(HCC)射频消融(RFA)中用于评估消融边缘的可行性,以及技术成功初始评估错误的可能原因。
回顾性分析467例接受RFA治疗的1100例HCC患者。17例患者尽管根据消融后24小时获得的对比增强图像初步判断消融成功,但仍出现局部肿瘤进展(LTP)(中位大小1.0 cm)。通过叠加消融前后的融合图像对消融边缘进行放射学重新评估。
17例LTP的初始分类为A级(绝对治愈)( = 5)和B级(相对治愈)( = 12);然而,重新评估将反应类别改变为8例C级(边缘零消融)和9例D级(存在残留HCC)。重新分级为C级的8例患者在4至30.3个月(中位14.3个月)内出现LTP,重新分级为D级的9例患者在2.4至6.7个月(中位4.2个月)内出现LTP( = 0.006)。消融周围充血增强掩盖了所有重新评估为D级的9例HCC。
并排比较对HCC的LTP存在误诊风险。叠加融合成像技术可用于高精度评估HCC消融边缘。